Exploring the role of ribosomal RNA modifications in cancer

Judith López1, Sandra Blanco1

  • 1Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC) - University of Salamanca, 37007 Salamanca, Spain; Instituto de Investigación Biomédica de Salamanca (IBSAL), Hospital Universitario de Salamanca, 37007 Salamanca, Spain.

Insights

Altered ribosomal RNA (rRNA) modifications are key in cancer, impacting protein synthesis and cell growth. Targeting these rRNA changes shows therapeutic promise for cancer treatment.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Biochemistry

Background:

  • Post-transcriptional modifications of ribosomal RNA (rRNA) play crucial roles in various cancers.
  • Dysregulation of rRNA modifications is increasingly recognized as a common factor in cancer development.
  • These alterations provide cancer cells with a competitive advantage by influencing protein synthesis.

Purpose of the Study:

  • To review the latest insights into how post-transcriptional rRNA modifications contribute to cancer progression.
  • To summarize key developments and ongoing challenges in the research of rRNA modifications in cancer.
  • To highlight the potential of rRNA modifications as biomarkers and therapeutic targets.

Main Methods:

  • This review synthesizes recent findings from molecular biology and cancer research.
  • It analyzes evidence linking rRNA modification patterns to cancer development and progression.
  • Preclinical studies and in vitro experiments investigating therapeutic inhibition are discussed.

Main Results:

  • rRNA modifications critically modulate protein synthesis, favoring the translation of oncogenic programs.
  • Altered rRNA modification patterns contribute to a protumorigenic proteome in cancer cells.
  • Inhibition of these modifications shows potential therapeutic efficacy in preclinical models.

Conclusions:

  • Altered rRNA modification patterns are recurrent across diverse cancer types, underscoring their significance.
  • These modifications represent a novel regulatory layer in cancer biology.
  • Targeting rRNA modifications offers promising avenues for novel cancer biomarkers and therapies.

Related Concept Videos

Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Ribosomal RNA Synthesis02:53

Ribosomal RNA Synthesis

Ribosome synthesis is a highly complex and coordinated process involving more than 200 assembly factors. The synthesis and processing of ribosomal components occurs not only in the nucleolus but also in the nucleoplasm and the cytoplasm of eukaryotic cells.
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
13.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Transfer RNA Synthesis02:36

Transfer RNA Synthesis

One of the unique features of tRNA is the presence of modified bases. In some tRNAs, modified bases account for nearly 20% of the total bases in the molecule. Altogether, these unusual bases protect the tRNA from enzymatic degradation by RNases.
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
11.9K
Translation01:31

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
14.8K